UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032783
Receipt number R000037399
Scientific Title Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome: a cross-sectional study
Date of disclosure of the study information 2018/05/30
Last modified on 2018/11/29 10:07:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome: a cross-sectional study

Acronym

Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome(PR-NAFLD)

Scientific Title

Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome: a cross-sectional study

Scientific Title:Acronym

Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome(PR-NAFLD)

Region

Japan


Condition

Condition

polycystic ovary syndrome

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the prevalence of NAFLD in polycystic ovary syndrome and risk factors of NAFLD in Japanese women.

Basic objectives2

Others

Basic objectives -Others

To investigate the prevalence of NAFLD in polycystic ovary syndrome and risk factors of NAFLD in Japanese women.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Prevalence of NAFLD (Alanine aminotransferase (ALT) > 19 IU/L)

Key secondary outcomes

Risk factors of NAFLD


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

Meet all of the following:
1) Women visited the Department of Gynecology in our Center from January 1, 2000 to September 30, 2016.
2) Women with confirmed diagnosis of polycystic ovary syndrome.
3) ALT data available

Key exclusion criteria

Fall under any of the following:
1) Missing data of body height, weight and BMI
2) Women with history of liver diseases
3) Pregnant women

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Yamaguchi

Organization

National Hospital Organization Kyoto Medical Center

Division name

Department of Obstetrics and Gynecology

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, JAPAN

TEL

+81-75-641-9161

Email

kyamaguc@kyotolan.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satomi Minato

Organization

Clinical Research Institute, National Hospital Organization Kyoto Medical Center

Division name

Department of Preventive Medicine

Zip code


Address

1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, JAPAN

TEL

+81-75-641-9161

Homepage URL


Email

sminato@kyotolan.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 30 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 05 Month 21 Day

Date of IRB


Anticipated trial start date

2018 Year 05 Month 31 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To investigate the prevalence of NAFLD in polycystic ovary syndrome and risk factors of NAFLD in Japanese women.


Management information

Registered date

2018 Year 05 Month 30 Day

Last modified on

2018 Year 11 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037399


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name